GET DAILY SIGNALSMarchex (MCHX): Aiming for a +54% Move Toward $2.00
Key Takeaways
- The central price objective examined here is $2.00, a move of roughly 54% above the latest market price near $1.30.
- Because Marchex, Inc. (MCHX), a Seattle-based, AI-driven conversation analytics and customer-acquisition company, has effectively only one current, attributable analyst target, this $2.00 figure is drawn from public technical discussion — specifically the stock's 52-week high and a key resistance zone — rather than a multi-analyst consensus.
- The single verified analyst price target is $4.00 from Northland Securities (Buy, reiterated in August 2026), implying a far larger but much less certain upside; it is context, not the central target.
- The strongest supporting factor is the July 2026 acquisition of Archenia, which drove management's Q3 2026 revenue guidance to $16.0–$16.5 million, a step-change from $11.0 million in Q2.
- The biggest risks are heavy customer concentration (the top 100 accounts generate roughly 90% of revenue), a thin cash position of about $8.2 million, and unproven integration and cross-sell execution.
- You can dig deeper into this ticker's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages.
- Explore Trending AI Robots to see how automated strategies are tracking opportunities like this one.
How the $2.00 Price Objective Came Together
Marchex is a thinly covered micro-cap. The only clearly current, attributable analyst price target found across data providers is $4.00 from Northland Securities, which reiterated a Buy rating in August 2026. A single target cannot form a meaningful "analyst consensus," so the stock forecast framework here instead uses the fallback approach: a realistic price objective resting on identifiable public discussion.
That objective is $2.00, the stock's 52-week high and a widely referenced resistance level (Yahoo Finance lists the 52-week range at roughly $1.15 to $2.00). As a round-number psychological level and a prior peak, $2.00 is a credible technical milestone rather than a fabricated forecast. It is at least 10% above the current price yet not unrealistically distant, unlike the $4.00 analyst figure, which represents a 200%-plus move.
Current Market Position and the Path to the Target
At a recent price near $1.30, Marchex carries a market capitalization of roughly $57.6 million. Reaching $2.00 would require a gain of about 54%, which is a substantial move for a stock that has spent much of its recent range between $1.15 and $2.00.
The potential path runs through execution on the Archenia acquisition, which closed on July 1, 2026. Marchex reported Q2 2026 revenue of $11.0 million, modestly higher sequentially but down year over year, and guided Q3 revenue to $16.0–$16.5 million with adjusted EBITDA of $2.3–$2.5 million as Archenia's first full quarter flows through. Management has framed a long-term ambition to grow toward $100 million in annual revenue and a "Rule of 30–40" profile (combining revenue growth and adjusted EBITDA margin). Converting early pilot and cross-sell wins into recurring, scalable revenue is the crux of any re-rating toward $2.00. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Factors That Could Support a Move Higher
- Transformative acquisition: Archenia adds AI-powered lead qualification and performance-marketing technology, extending Marchex from analytics into automated actions and measurable outcomes.
- Guidance step-up: Q3 2026 guidance implies sequential revenue growth of roughly 45–50% and a path to positive adjusted EBITDA, a sharp contrast to the prior revenue declines.
- Cross-sell evidence: Management cited a home-services client expanding from about $500,000 to over $1 million in annualized revenue after adopting AI-verified outcomes, plus other expanding pilots.
- Low valuation and aligned insiders: The shares trade near roughly 1.2x forward revenue on annualized guidance, and insiders own about one-third of the equity, alongside a 3 million-share buyback authorization.
Risks That Could Keep the Target Out of Reach
- Execution and integration risk: Archenia is an early-stage business; its standalone margins are unverified, and merging two platforms takes time.
- Customer concentration: The top 100 customers account for about 90% of revenue, so a few renewals or stalled cross-sells can swing results meaningfully.
- Thin balance sheet: Cash fell to about $8.2 million at Q2-end after a roughly $10 million cash acquisition, leaving limited cushion if growth requires further investment.
- Valuation and sentiment risk: The market has not yet rewarded the growth narrative, and a history of revenue decline could reassert itself if the combined business disappoints.
Technical Levels and Market Structure
The 52-week range of approximately $1.15 to $2.00 defines the durable structure. The $2.00 area is the principal resistance level — a prior peak and round number — while $1.15 marks the key support level below. The stock has recently traded in the lower half of this range and below its 200-day moving average (cited near $1.58 in recent commentary), meaning a sustained move toward $2.00 would first require reclaiming that intermediate zone and then clearing the upper boundary of the range. From what I see, monitoring these levels closely makes sense given the event-driven nature of the name.
Time Horizon and Key Items to Watch
The $2.00 milestone is a technical objective without a formal research horizon; the single $4.00 analyst target typically reflects a roughly 12-month view. The most important near-term catalyst is the Q3 2026 earnings report, expected in early November 2026, when management plans to provide Q4 guidance and an initial 2027 outlook. Investors should watch revenue versus the $16.0–$16.5 million guide, adjusted EBITDA versus $2.3–$2.5 million, cash trends, and whether the named customer pilots convert into contracted, recurring deployments. Any analyst target changes or new coverage would also matter, given how little coverage the stock has. I’m watching this closely ahead of the print.
AI Daily Buy/Sell Signals
I often turn to Tickeron’s AI Daily Buy/Sell Signals when following names like this. The tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. For a thinly traded, event-driven name like Marchex, these signals can help surface shifting momentum, track positions, and spot emerging trends more efficiently than manual scanning. Traders looking to stay ahead of developing opportunities may find the AI Daily Buy/Sell Signals a useful complement to their own research.
Final Assessment
Whether Marchex (MCHX) can reach $2.00 depends on the company delivering on the Archenia integration and converting early cross-sell wins into durable, recurring revenue. The required 54% move is substantial, and the objective is a technical milestone rather than a consensus forecast — the one attributable analyst target of $4.00 is far more ambitious and rests on a single firm's view. The step-change in revenue guidance and a low valuation provide a credible foundation for the bullish case, while customer concentration, a thin cash position, and execution risk remain the principal obstacles. The Q3 2026 report and its 2027 outlook are the clearest next test.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MCHX's RSI Indicator peaks and leaves overbought zone
The 10-day RSI Indicator for MCHX moved out of overbought territory on October 30, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 instances where the indicator moved out of the overbought zone. In 22 of the 22 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
MCHX moved below its 50-day moving average on November 03, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for MCHX moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCHX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
MCHX broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MCHX entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on MCHX as a result. In 68 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The 10-day moving average for MCHX crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +4.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where MCHX advanced for three days, in 161 of 221 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.016) is normal, around the industry mean (-1.802). P/E Ratio (-10.154) is within average values for comparable stocks, (21.593). Projected Growth (PEG Ratio) (0.780) is also within normal values, averaging (1.501). MCHX's Dividend Yield (1.515) is considerably higher than the industry average of (0.084). P/S Ratio (1.439) is also within normal values, averaging (1.860).
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. MCHX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MCHX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of advertising and marketing services
Industry AdvertisingMarketingServices
Advertisement